South West Kent PBC Group and GSK
South West Kent PBC Group and GlaxoSmithKline are engaged in joint working to enhance the management of Chronic Obstructive Pulmonary Disease (COPD) to a standard of care defined by NICE (National Institute for Health and Clinical Excellence).
Both parties have committed resources to support this project, which will run from August 2010 – August 2011
The objective of this Joint Working project is to improve quality and productivity in the management of patients with COPD within the PBC group.
It is designed to support:
- The promotion of disease prevention and the earlier identification of patients with COPD through healthcare professional education.
- Accurate diagnosis and classification of disease with access to high quality information.
- Prevention of COPD exacerbations through increased patient review and appropriate use of medications in line with NICE guidance.
- Improving the quality of COPD referrals to secondary care and community teams.
- Equitable, cost effective service delivery across all practices in the PBC group.
For further information please contact:
Pauline Mooney, Area Business Manager, GSK.
Email: pauline.e.mooney@gsk.com
UK/PPM/0060/10 - August 2010